Cure Today1d
GAP Regimen May Not Improve Survival in Biliary Tract Cancer Subset
The addition of nab-paclitaxel to gemcitabine and cisplatin did not improve survival in advanced biliary tract cancer.
Hosted on MSN3d
Shining a Light on Biliary Cancers: The challenge of cholangiocarcinoma and gallbladder cancer
February is National Cancer Awareness Month, a time to amplify discussions on lesser- known but equally devastating ...
Medscape2mon
Differential Diagnosis of Intrahepatic Bile Duct Dilatation Without Demonstrable Mass On Ultrasonography or CT: Benign Versus Malignancy
Hong Joo Kim; Kyu Taek Lee; Seung Hoon Kim; Jong Kyun Lee; Jae Hoon Lim; Seung Woon Paik; Jong Chul Rhee Extrahepatic cholangiocarcinoma is usually evident on cholangiogram, but the intrahepatic ...
ascopubs.org23d
Positive homologous recombination signature (HRDsig+) and the genomic landscape of intrahepatic cholangiocarcinoma (iCCA).
Clinical landscape of cell free DNA alterations in patients with advanced biliary tract cancer treated with targeted therapies.
Hosted on MSN1mon
New hope for patients with deadly bile duct cancer
In the new study, patients diagnosed with the three main types of bile duct cancer (intrahepatic, perihilar or distal cholangiocarcinoma) or with cancer of the gallbladder could be eligible to ...
ascopubs.org23d
Tumor vascularity as a predictor of FGFR inhibitor response in FGFR2-fused intrahepatic cholangiocarcinoma.
Expression of Trop2, Nectin-4, and FOLR1 cell surface markers in biliary tract cancers: Is it time to repurpose drugs? This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...
Morningstar22d
Elevar Therapeutics Announces the Formation and Members of Scientific Advisory Board
fusions in patients with intrahepatic cholangiocarcinoma, with the first demonstration of anti-tumor activity with FGFR inhibitors in this patient population. Subsequent work led to the FDA ...
Medscape7d
Differential Diagnosis of Intrahepatic Bile Duct Dilatation Without Demonstrable Mass On Ultrasonography or CT: Benign Versus Malignancy
Some researchers have recommended that although the diagnosis of cholangiocarcinoma should ... we present 24 patients with intrahepatic bile duct dilation and no mass lesion demonstrated on ...